NASDAQ
Total Transactions
4
0 buys /4 sells
Shares Acquired
0
Transactions: 0•Avg: 0
Shares Disposed
11,650
Transactions: 4•Avg: 2,912.5
Net Activity
-11,650
Net Selling•Ratio: 0%
Q4 2025(Current) | 0 | 11,650 | -11,650 | 0.00% |
Q3 2025 | 4,207 | 584,084 | -579,877 | 25.00% |
Q2 2025 | 77,867 | 46,664 | +31,203 | 109.09% |
Q1 2025 | 1,680,368 | 496,765 | +1,183,603 | 40.43% |
Q4 2024 | 75,179 | 154,273 | -79,094 | 32.35% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 11,650 shares•Acquired/Disposed Ratio: 0%
Net Activity | |||||
|---|---|---|---|---|---|
ER Elghandour Rami | Director, officer: see remarks | 14 | 1,362,943 | 715,983 | +646,960 |
GAH Galligan Andrew H | Director | 3 | 18,613 | 0 | +18,613 |
MK Myers Kristin | Director | 3 | 18,613 | 0 | +18,613 |
HC Heery Christopher | Officer: chief medical officer | 24 | 104,354 | 119,832 | -15,478 |
BA Behbahani Ali | Director | 3 | 13,381 | 0 | +13,381 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-11-17 | Officer: chief medical officer | Sale | 340 | $90 | $30,600 | 284 | |
2025-10-15 | Officer: chief financial officer | Sale | 5,364 | $91.04 | $488,315.49 | 8,466 | |
2025-10-03 | Officer: chief financial officer | Sale | 4,882 | $86 | $419,869.58 | 14,894 | |
2025-10-06 | Officer: chief financial officer | Sale | 1,064 | $86.22 | $91,733.29 | 13,830 | |
2025-09-30 | Officer: chief medical officer | Sale | 5,300 | $80.55 | $426,924.54 | 16,358 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
HC Heery Christopher | Officer: chief medical officer | Nov 17, 2025 | |
GM Gilson Michelle | Officer: chief financial officer | Oct 15, 2025 | |
GM Gilson Michelle | Officer: chief financial officer | Oct 6, 2025 | |
GM Gilson Michelle | Officer: chief financial officer | Oct 6, 2025 | |
HC Heery Christopher | Officer: chief medical officer | Sep 30, 2025 |
Net change in shares shown on right
No price data available for this timeframe.